Human papillomavirus (HPV) 16 E6 sensitizes cells to atractyloside- lnduced apoptosis: Role of p53, ICE-like proteases and the mitochondrial permeability transition

Journal of Cellular Biochemistry

Volumn 66, Issue 2, 1997, Pages 245-255

  Brown, Jacqueline ^a,c   Higo, Hiromi ^a,d   McKalip, Ann ^a   Herman, Brian ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c SPELMAN COLLEGE   (United States)

^d NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

Author keywords

Apoptosis; HPV; ICE like proteases; Mitochondrial permeability transition; P53

Indexed keywords

ATRACTYLOSIDE; DNA FRAGMENT; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN BCL 2; PROTEIN P53; PROTEINASE; VIRUS PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL STRAIN 3T3; CONTROLLED STUDY; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; UTERINE CERVIX CARCINOMA; WART VIRUS;

ANIMALS; APOPTOSIS; ATRACTYLOSIDE; CARCINOMA; CASPASE 1; CELL LINE; CYCLOSPORINE; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; DNA FRAGMENTATION; FEMALE; FIBROBLASTS; HUMANS; INTERLEUKIN-1; INTRACELLULAR MEMBRANES; MICE; MITOCHONDRIA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; REPRESSOR PROTEINS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 0030743414     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19970801)66:2<245::AID-JCB11>3.0.CO;2-G     Document Type: Article

References (62)

1. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P (1995): Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Cell 15:961-973.
2. Bakhshi A, Jensen JP, Goldman P, Wright JJ, McBride OW, Epstein AL, Korsemeyer SJ (1985): Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around J-H on chromosome 14 and near a transcriptional unit on 18. Cell 41:899-906.
3. Bernardi P, Broekemeier KM, Pfeiffer DR (1994): Recent progress on regulation of the mitochondrial permeability pore: A cyclosporin-sensitive pore in the inner mitochondrial membrane. J Bioenerg Biomembr 26:509-517.
4. Broekemeier KM, Dempsey ME, Pfeiffer DR (1989): Cyclosporin A is a potent inhibitor of the inner membrane transition in mitochondria. J Biol Chem 264:7826-7830.
5. Butz K, Shahabeddin L, Geisen C, Spitkovsky D, Ullman A, Hoppe-Seyler F (1995): Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene 10:927-936.
6. Chen PL, Chen YM, Bookstein R, et al. (1990): Genetic mechanisms of tumor suppression by the human p53 gene. Science 250:1576-1580.
7. Clarke AR, Purdie CA, Harison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH (1993): Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852.
8. Cleary ML, Sklar J (1985): Nucleotide sequence of a t(14; 18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439-7443.
9. de Macedo DV, Nepomuceno ME, Pereira-da-Silva L (1993): Involvement of the ADP/ATP carrier in permeabilization processes of the inner mitochondrial membrane. Eur J Biochem 215:595-600.
10. Eliyahu D, Michalovitz D, Eliyahu S, Pinhasi-Kimhi O, and Oren M (1989): Wild-type p53 can inhibit oncogene-mediated focus formation. Proc Natl Acad Sci USA 86: 8763-8767.
11. Finlay CA, Hinds PW, Levine AJ (1989): The p53 protooncogene can act as a suppressor of transformation. Cell 57:1083-1093.
12. Foster SA, Demers GW, Etscheid BG, Galloway DA (1994): The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J Virol 68:5698-5705.
13. 2+-induced large amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to the mitochondrial matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J 268:153-160.
14. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993): The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
15. Hawkins DS, Demers GW, Galloway DA ( 1996): Inactivation of p53 enhances sensitivity to multiple chemotheraputic agents. Cancer Res 56:892-898.
16. Ishiwatari H, Hayasaka N, Inoue H, Yutsudo M, Hakura A (1994): Degradation of p53 only is not sufficient for the growth stimulatory effect of human papillomavirus 16 E6 oncoprotein in human embryonic fibroblasts. J Med Virol 44:243-249.
17. Jacobson MD, Burne JF, Raff MC (1994): Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 13:1899-1910.
18. Kerr JFR, Wyllie AH Currie AR (1972): Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257.
19. Klingenberg M (1980): The ADP-ATP translocation in mitochondria, a membrane potential controlled transport. J Membr Biol 56:97-105.
20. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC (1993): Investigations of the subcellular distribution of the BCL-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53:4701-4714.
21. Krippner A, Matsuno-Yagi A, Gottleib RA, Babior BM (1996): Loss of function of cytochrome c in Jurkat cells undergoing Fas-mediated apoptosis. J Biol Chem 271:21629-21636.
22. Lane DP, Crawford L (1979): T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261-263.
23. Liang XH, Mungal S, Ayscue A, Meissner J, Wodnicki P, Hockenbery D, Lockett S, Herman B ( 1994): Bcl-2 protooncogene expression in cervical carcinoma cell lines containing inactive p53. J Cell Biochem 57:509-520.
24. Linzer DIH, Levine AJ (1979): Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17:43-52.
25. Lowe SW, Schmitt EM, Smith SW, Osvorne BA, Jacks T (1993): p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-852.
26. Lowe SW, Jacks T, Housman DE, Ruley E (1994): Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl Acad Sci USA 91: 2026-2030.
27. Majima E, Shinohara Y, Yamaguchi N, Hong YM, Terada H (1994): Importance of loops of mitochondrial ADP/ATP carrier for its transport activity deduced from reactivities of its cysteine residues with the sulphydril reagent eosin-5-maleimide. Biochemistry 33:9530-9536.
28. 2 in mitochondria enriched with n-3 fatty acids. Proc Natl Acad Sci USA 87:8845-8849.
29. Marchetti P, Catedo M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffner A, Hirsch F, Geuskens M, Kroemer G (1995): Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med 184:1155-1160.
30. Martin SJ, Green DR (1995): Protease activation during apoptosis: Death by a thousand cuts. Cell 82:349-352.
31. Marty I, Brandolin G, Gagnon J, Brasseur R, Vignain PV (1992): Topography of the membrane-bound ADP/ATP carrier assessed by enzymatic proteolysis. Biochemistry 31:4058-4065.
32. Merrick BA, He C, Witcher LL, Patterson RM, Reid JJ, Pence-Pawlowski PM, Selkirk JK (1996): HSP binding and mitochondrial localization of p53 protein in human HT1080 and mouse C3H10T1/2 cell lines. Biochem Biophys Acta 1297:57-68.
33. Miura M, Zhu H, Rotello R, Hartwieg E, Yuan J (1993): Induction of apoptosis in fibroblasts by IL-1-beta-converting enzyme, a mammalian homolog of the C. clegans cell death gene ced-3. Cell 75:653-660.
34. Miyashita T, Krajewski S, Krejewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC (1995): Tumor suppressor p53 is a direct transcriptional regulator of the human bax gene. Cell 80:293-299.
35. Nakajima H, Golstein P, Henkart PA (1995): The target cell nucleus is not required for cell-mediated granzyme or Fas-based cytotoxicity. J Exp Med 181:1905-1909.
36. Newmeyer DD, Farschon DM, Reed JC (1994): Cell free apoptosis in xenopus egg extracts: Inhibition by Bcl-2 and requirement for an organelle fraction enriched in mitochondria. Cell 79:353-364.
37. Pastorino JG, Snyder JW, Serroni A, Hoek JB, Farber JL (1993): Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition. J Biol Chem 268:13791-13798.
38. 2+. J Biol Chem 268:1011-1016.
39. Sarnow P, Ho YS, Williams J, Levine AJ (1982): Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 28:387-394.
40. Schulze-Osthoff K, Walczak H, Drogu W, Krammer PH (1994): Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol 127:15-20.
41. Shimizu S, Eguchi Y, Kamiike W, Waguri S, Uchiyama Y, Matsuda H, Tsujimoto Y (1996): Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death by respiratory chain inhibitors. Oncogene 13:21-29.
42. Sokolove PM, Rester MB, Haynes J (1993): Interaction of adriamycin aglycones with isolated mitochondria. Effect of selenium deficiency. Biochem Pharmacol 46:691-697.
43. 1 phase which can be substituted for mutations in p53. Oncogene 11:653-661.
44. Susin SA, Zamzami N, Catedo M, Hirsch T, Marchetti P, Macho A, Daugas E, Geuskens M, Kroemer G (1996): Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 184:1331-1341.
45. Szabo I, Zoratti M (1991): The giant channel of the inner mitochondrial membrane is inhibited by cyclosporin A. J Biol Chem 266:3376-3379.
46. 2+-dependent inner-membrane permeability transition. Biochem J 294: 719-725.
47. 2+ and phosphate. Biochem Biophys Res Commun 111:792-797.
48. Tsujimoto Y, Croce CM (1986): Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83:5214-5218.
49. Tsujimoto Y, Cossman J, Jaffe E, Croce C (1985a): Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440-1443.
50. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM (1985b): The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229:1390-1393.
51. Werness BA, Levine AJ, Howley PM (1990): Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79.
52. Whyte M (1996): ICE/CED-3 proteases in apoptosis. Trends Cell Biol 6:245-248.
53. Wolvetang EJ, Johnson KL, Krauer K, Ralph SJ, Linnane AW (1994): Mitochondrial respiratory chain inhibitors induce apoptosis. FEBS Lett 339:40-44.
54. Wyllie AH, Kerr JFR, Currie AR (1980): Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306.
55. Xu C, Meikrantz W, Schlegel R, Sager R (1995): The human papillomavirus 16E6 gene sensitizes human mammary cells to apoptosis induced by DNA damage. Proc Natl Acad Sci USA 92:7829-7833.
56. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin S, Petit PX, Mignotte B, Kroemer G (1995a): Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 182:367-377.
57. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JL, Petit PX, Kroemer G (1995b): Reduction in mitochondrial membrane potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J Exp Med 181:1661-1672.
58. Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Montery I, Castedo M, Kroemer G (1996a): Mitochondrial control of apoptosis. J Exp Med 183:1533-1544.
59. Zamzami N, Marchetti P, Catedo M, Hirsch T, Susin SA, Masse B, Kroemer G (1996b): Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis. FEBS Lett 384:53-57.
60. Zha H, Fisk HA, Yaffe MP, Mahajan M, Herman B, Reed JC (1996): Structure functions comparisons of pro-apoptotic protein bax in yeast and mammalian cells. Mol Cell Biol 16:6494-6508.
61. Zoratti M, Szabo I (1995): The mitochondrial permeability transition. Biochim Biophys Acta Rev Biomembr 1241: 139-176.
62. zur Hausen H (1982): Human genital cancer: Synergism between two virus infections or synergism between a virus infection and initiating events. Lancet 2:1370-1372.